RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cell Kinetics Stock

Cell Kinetics ROCE 2024

Cell Kinetics ROCE

0

Ticker

CKNTF

ISIN

IL0011098758

WKN

A0MV4W

In 2024, Cell Kinetics's return on capital employed (ROCE) was 0, a 0% increase from the 0 ROCE in the previous year.

Cell Kinetics Aktienanalyse

What does Cell Kinetics do?

Cell Kinetics Ltd is a company specializing in the research and production of cell therapy products. The company was founded in 2020 and is based in London, United Kingdom. Cell Kinetics Ltd has a visionary mission that inspires the company to discover and develop groundbreaking solutions to improve people's health and well-being. The company aims to research, develop, and deliver therapies for serious diseases such as cancer and neurodegenerative disorders. The business model of Cell Kinetics Ltd is based on comprehensive research of new cell therapies and collaboration with academic partners to validate the clinical benefits of these therapies. The company has established partnerships with leading academic institutions and medical centers in Europe and the USA. Cell Kinetics Ltd works in various areas to achieve the goal of discovering and developing new therapies for serious diseases. An important focus of the company is the development of cell culture methods for the production and maintenance of therapeutic cells in large quantities. The company has extensive experience in developing artificial platforms for cell cultivation, including bioreactor-based cultivation, single-cell-sensitive cultivation, and the use of chemicals for cell cultivation. Another focus of Cell Kinetics Ltd is the development of carcinoma therapies. The company has developed a special technology for the production of T-cells that can be used to kill cancer cells. These T-cells are obtained from blood samples of cancer patients and cultivated in vitro. The company has also developed a technology that allows these T-cells to be modified to fight deadly diseases such as leukemia and lymphoma. Another focus of Cell Kinetics Ltd is the development of therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. The company is developing special technologies to differentiate neural stem cells that can serve as a therapeutic tool for the treatment of these diseases. These neural stem cells can be used to repair damaged nerve cells. Cell Kinetics Ltd is proud to offer a range of products that can contribute to improving the health and well-being of patients. The company offers therapy products for cancer treatment, neurodegenerative diseases, and cardiovascular diseases, among others. In addition, the company also provides a wide range of services, including the development and production of cell therapy products, as well as artificial platforms for cell cultivation. Overall, Cell Kinetics Ltd has become a major player in the field of cell therapy and the development of therapies for serious diseases. The company is committed to continuing to develop groundbreaking discoveries and technologies to improve the lives of millions of people around the world. Cell Kinetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Cell Kinetics's Return on Capital Employed (ROCE)

Cell Kinetics's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Cell Kinetics's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Cell Kinetics's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Cell Kinetics’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Cell Kinetics stock

What is the ROCE (Return on Capital Employed) of Cell Kinetics this year?

The ROCE of Cell Kinetics is 0 undefined this year.

How has the ROCE (Return on Capital Employed) of Cell Kinetics developed compared to the previous year?

The ROCE of Cell Kinetics has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Cell Kinetics?

A high Return on Capital Employed (ROCE) indicates that Cell Kinetics has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Cell Kinetics?

A low ROCE (Return on Capital Employed) can indicate that Cell Kinetics has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Cell Kinetics impact the company?

An increase in the ROCE of Cell Kinetics can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Cell Kinetics affect the company?

A decrease in ROCE of Cell Kinetics can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Cell Kinetics?

Some factors that can affect Cell Kinetics's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Cell Kinetics so important for investors?

The ROCE of Cell Kinetics is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Cell Kinetics take to improve the ROCE?

To improve the ROCE, Cell Kinetics can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Cell Kinetics pay?

Over the past 12 months, Cell Kinetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cell Kinetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Cell Kinetics?

The current dividend yield of Cell Kinetics is .

When does Cell Kinetics pay dividends?

Cell Kinetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cell Kinetics?

Cell Kinetics paid dividends every year for the past 0 years.

What is the dividend of Cell Kinetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cell Kinetics located?

Cell Kinetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cell Kinetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cell Kinetics from 10/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Cell Kinetics pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Cell Kinetics in the year 2023?

In the year 2023, Cell Kinetics distributed 0 USD as dividends.

In which currency does Cell Kinetics pay out the dividend?

The dividends of Cell Kinetics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cell Kinetics

Our stock analysis for Cell Kinetics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cell Kinetics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.